viernes, 6 de noviembre de 2026
BuscarExplore
es.VIA.NEWS
Via News Knowledge File

Bank of America

organization80% conf.·synced Nov 6, 2026

Investment bank providing analyst coverage of Netflix

60
sourced metrics
885
relationships
20
stated objectives
5
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Stock Price
49.76USD
Nov 5, 2026reference only
Price 52 Week High
64.81USD
Nov 5, 2026reference only
Market Cap
347959158642USD
Nov 5, 2026reference only
Price 52 Week Low
46.72USD
Nov 5, 2026reference only
Stock Return Ytd
-11.1%
Nov 5, 2026reference only
Shares Outstanding
6992748365.0shares
Jul 30, 2026reference only
Total Assets
3499191000000.0USD
Jun 30, 2026reference only
Stockholders Equity
301094000000.0USD
Jun 30, 2026reference only
Revenue
31558000000.0USD
Jun 30, 2026reference only
Eps
1.21USD_per_share
Jun 30, 2026reference only
Net Income
9074000000.0USD
Jun 30, 2026reference only
Total Liabilities
3198097000000.0USD
Jun 30, 2026reference only
Operating Cash Flow
41770000000.0USD
Mar 31, 2026reference only

Stated objectives

Earnings growth in the medium term

source
target: 12% stated

Approve modest crypto allocations for private wealth clients

source
by 2026-01-01 00:00:00stated

Net interest income growth target for 2026

source
target: 5-7% growth by 2026-12-31 00:00:00stated

Maintain operating leverage by growing revenue faster than expenses

source
target: positive operating leverage by 2026-12-31 00:00:00stated

Prepare the next generation of innovators who will shape the Charlotte community through hands-on STEM experiences

source
stated

Prepare the next generation of innovators who will shape the Charlotte community through hands-on STEM experiences

source
stated

Invest in hands-on experiences that spark curiosity, unlock potential and help prepare the next generation of innovators who will shape Charlotte community

source
stated

Deploy US$25 billion into private credit transactions to expand direct lending platform

source
target: 25 billion USD stated

Price target of $15 per share for Tripadvisor

source
target: 15 stated

Tech stocks expected to see record $75 billion inflow in 2025

source
target: 75_billion_USD by 2025-12-31 00:00:00stated

Relationship graph · 885 connections

Covered by
337
Employs
211
rates
75
Competes with
62
Invested in
26
subsidiary of
22
Developed by
19
financed by
17
employed by
Aditya Bhave

Via News coverage

Palantir sube en las apuestas de los analistas mientras Wall Street enfría al sector de defensa: lo que sí está verificado, y lo que no
October 19, 2026
La fiebre de la infraestructura de IA: Micron duplica su inversión mientras los analistas avisan de valoraciones al límite
October 9, 2026
El auge de la infraestructura de IA, medido en las cuentas de Micron: el gasto en inversión se duplicó en dos años mientras el consumo y la tecnología especulativa flaquean
October 1, 2026
La apuesta financiera de $108 mil millones de Buffett: Por qué el 35% de la cartera de Berkshire está en 5 acciones
January 25, 2026
Los futuros de acciones de EE.UU. caen mientras los mercados reaccionan a la reciente corrección
January 14, 2026
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,996
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,996 hechos verificados con la fuente5,552 documentos fuente archivados
Consulta estos datos → isubstrate.com